Skip to Main Content

Paper Details

Influence of Concurrent and Adjuvant Temozolomide on Health-Related Quality of Life of Patients with Grade III Gliomas: A Secondary Analysis of a Randomized Clinical Trial (KNOG-1101 Study).
Cancer Res Treat
2
2022
Brain Neoplasm, Cancer, Grade III Gliomas, Patients, Temozolomide, WHO grade III glioma, anaplastic gliomas, appetite loss, constipation, diarrhea, drowsiness, dyspnea, fatigue, hair loss, itchy skin, nausea and vomiting, patients, seizures, temozolomide
Author NameAffiliation
Grace S AhnSeoul National University Bundang Hospital, Seoul National University College of Medicine
Chul-Kee ParkSeoul National University Hospital, Seoul National University College of Medicine
Do-Hyun NamSamsung Medical Center, Sungkyunkwan University School of Medicine
Do-Hyun NamSamsung Medical Center, Sungkyunkwan University School of Medicine
Heon YooDepartment of Neuro-Oncology Clinic, Center for Specific Organs Cancer, National Cancer Center Hospital, National Cancer Center
Eun Young KimInha University Hospital, Inha University School of Medicine
  • 1 - 6

Datasets

Release 1.2